Skip to content

Citius Oncology, Inc. CTOR General and administrative costs

General and administrative costs at other companies

OS Therapies logo
OS TherapiesOSTX
$2.82M-23.7%
KRAKacquisition
 logo
KRAKacquisition KRAQ
$10.97M
RFL
Rafael Holdings, Inc.RFL
$2.14M-32.5%
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$183.2K-10.4%
CTO
Citius Oncology, Inc.CTOR
$23.63M+953%
NXT
Next Technology HoldingNXTT
$4.25M+845%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s general and administrative costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s general and administrative costs?
Citius Oncology, Inc. (CTOR) reported general and administrative costs of $23.63M in Q1 2026.
How has Citius Oncology, Inc.'s general and administrative costs changed year-over-year?
Citius Oncology, Inc.'s general and administrative costs increased by 953.2% year-over-year, from $2.24M to $23.63M.
What is the long-term trend for Citius Oncology, Inc.'s general and administrative costs?
Over 2 years (2023 to 2025), Citius Oncology, Inc.'s general and administrative costs has grown at a 21.9% compound annual growth rate (CAGR), from $5.92M to $8.78M.
What does general and administrative costs mean?
Captures the costs associated with the day-to-day management and overhead of the organization, excluding direct research or production costs. Monitoring this helps investors assess the company's operational efficiency and the scalability of its corporate infrastructure.